Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 32, Issue 10, 2010, Pages 786-790

  Lin, L ^a   Xu, Jian ming ^b   Wang, Yan ^b   Ge, Fei jiao ^b   Liu, Lie jun ^b   Zhao, Chuan hua ^b   Li, Shan shan ^b   Liu, Jian zhi ^b   Li, Zhi qiang ^b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CA 19-9 ANTIGEN; CAMPTOTHECIN; CARCINOEMBRYONIC ANTIGEN; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COLLOID CARCINOMA; COLON TUMOR; DIARRHEA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; METASTASIS; MIDDLE AGED; NEUTROPENIA; RECTUM TUMOR; REMISSION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; CAMPTOTHECIN; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; DIARRHEA; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LEUCOVORIN; MALE; MIDDLE AGED; NEUTROPENIA; RECTAL NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84879791467     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)